Medications

Q&A: The legal drug crisis in the US

Three out of four American adults say prescription drug prices are unaffordable, and nearly a third admit to not taking prescribed medications due to cost, according to a recent poll conducted by the Kaiser Family Foundation. ...

Medical research

Clinical trials: Two arms are better than one

The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies.

Medications

Novartis generics unit Sandoz makes stock market debut

Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.

Diseases, Conditions, Syndromes

Q&A: Vaccines, variants and COVID-19 trends

COVID-19 hospitalizations in the United States were on the rise for weeks heading into mid-September, right as updated COVID-19 vaccines from Pfizer and Moderna started to be distributed across the country.

page 4 from 40